COVID-19 Impact on Global Transdermal and Transmucosal Drug Delivery Market Size, Status and Forecast 2020-2026
When injections and pills are counter-indicated, transdermal and transmucosal delivery systems may get drugs into the body with great efficacy and beneficial results.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transdermal and Transmucosal Drug Delivery market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Transdermal and Transmucosal Drug Delivery industry.
Based on our recent survey, we have several different scenarios about the Transdermal and Transmucosal Drug Delivery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Transdermal and Transmucosal Drug Delivery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal and Transmucosal Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal and Transmucosal Drug Delivery market in terms of revenue.
Players, stakeholders, and other participants in the global Transdermal and Transmucosal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Transdermal and Transmucosal Drug Delivery market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Transdermal and Transmucosal Drug Delivery market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal and Transmucosal Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal and Transmucosal Drug Delivery market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Transdermal and Transmucosal Drug Delivery market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Transdermal and Transmucosal Drug Delivery industry.
Based on our recent survey, we have several different scenarios about the Transdermal and Transmucosal Drug Delivery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Transdermal and Transmucosal Drug Delivery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal and Transmucosal Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal and Transmucosal Drug Delivery market in terms of revenue.
Players, stakeholders, and other participants in the global Transdermal and Transmucosal Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Transdermal and Transmucosal Drug Delivery market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Transdermal and Transmucosal Drug Delivery market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal and Transmucosal Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal and Transmucosal Drug Delivery market.
The following players are covered in this report:
- 3M
- Antares Pharma
- Aveva Drug Delivery Systems
- Corium International
- DURECT
- Pantec Biosolutions
- Tapemark
- Tesa Labtec
- Transdermal Drug Delivery
- Transmucosal Drug Delivery
- Clinics
- Hospitals
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transdermal and Transmucosal Drug Delivery Revenue
1.4 Market Analysis by Type
1.4.1 Global Transdermal and Transmucosal Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transdermal Drug Delivery
1.4.3 Transmucosal Drug Delivery
1.5 Market by Application
1.5.1 Global Transdermal and Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal and Transmucosal Drug Delivery Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal and Transmucosal Drug Delivery Industry
1.6.1.1 Transdermal and Transmucosal Drug Delivery Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal and Transmucosal Drug Delivery Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal and Transmucosal Drug Delivery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Transdermal and Transmucosal Drug Delivery Market Perspective (2015-2026)
2.2 Transdermal and Transmucosal Drug Delivery Growth Trends by Regions
2.2.1 Transdermal and Transmucosal Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transdermal and Transmucosal Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transdermal and Transmucosal Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Transdermal and Transmucosal Drug Delivery Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Transdermal and Transmucosal Drug Delivery Players by Market Size
3.1.1 Global Top Transdermal and Transmucosal Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Transdermal and Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transdermal and Transmucosal Drug Delivery Market Concentration Ratio
3.2.1 Global Transdermal and Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transdermal and Transmucosal Drug Delivery Revenue in 2019
3.3 Transdermal and Transmucosal Drug Delivery Key Players Head office and Area Served
3.4 Key Players Transdermal and Transmucosal Drug Delivery Product Solution and Service
3.5 Date of Enter into Transdermal and Transmucosal Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Transdermal and Transmucosal Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Type (2021-2026)
5 TRANSDERMAL AND TRANSMUCOSAL DRUG DELIVERY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
5.2 Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
6.2 Transdermal and Transmucosal Drug Delivery Key Players in North America (2019-2020)
6.3 North America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
6.4 North America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
7.2 Transdermal and Transmucosal Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
8 CHINA
8.1 China Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
8.2 Transdermal and Transmucosal Drug Delivery Key Players in China (2019-2020)
8.3 China Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
8.4 China Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
9.2 Transdermal and Transmucosal Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
10.2 Transdermal and Transmucosal Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
11 INDIA
11.1 India Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
11.2 Transdermal and Transmucosal Drug Delivery Key Players in India (2019-2020)
11.3 India Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
11.4 India Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
12.2 Transdermal and Transmucosal Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 3M
13.1.1 3M Company Details
13.1.2 3M Business Overview and Its Total Revenue
13.1.3 3M Transdermal and Transmucosal Drug Delivery Introduction
13.1.4 3M Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020))
13.1.5 3M Recent Development
13.2 Antares Pharma
13.2.1 Antares Pharma Company Details
13.2.2 Antares Pharma Business Overview and Its Total Revenue
13.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Introduction
13.2.4 Antares Pharma Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.2.5 Antares Pharma Recent Development
13.3 Aveva Drug Delivery Systems
13.3.1 Aveva Drug Delivery Systems Company Details
13.3.2 Aveva Drug Delivery Systems Business Overview and Its Total Revenue
13.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Introduction
13.3.4 Aveva Drug Delivery Systems Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.3.5 Aveva Drug Delivery Systems Recent Development
13.4 Corium International
13.4.1 Corium International Company Details
13.4.2 Corium International Business Overview and Its Total Revenue
13.4.3 Corium International Transdermal and Transmucosal Drug Delivery Introduction
13.4.4 Corium International Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.4.5 Corium International Recent Development
13.5 DURECT
13.5.1 DURECT Company Details
13.5.2 DURECT Business Overview and Its Total Revenue
13.5.3 DURECT Transdermal and Transmucosal Drug Delivery Introduction
13.5.4 DURECT Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.5.5 DURECT Recent Development
13.6 Pantec Biosolutions
13.6.1 Pantec Biosolutions Company Details
13.6.2 Pantec Biosolutions Business Overview and Its Total Revenue
13.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Introduction
13.6.4 Pantec Biosolutions Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.6.5 Pantec Biosolutions Recent Development
13.7 Tapemark
13.7.1 Tapemark Company Details
13.7.2 Tapemark Business Overview and Its Total Revenue
13.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Introduction
13.7.4 Tapemark Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.7.5 Tapemark Recent Development
13.8 Tesa Labtec
13.8.1 Tesa Labtec Company Details
13.8.2 Tesa Labtec Business Overview and Its Total Revenue
13.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Introduction
13.8.4 Tesa Labtec Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.8.5 Tesa Labtec Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transdermal and Transmucosal Drug Delivery Revenue
1.4 Market Analysis by Type
1.4.1 Global Transdermal and Transmucosal Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Transdermal Drug Delivery
1.4.3 Transmucosal Drug Delivery
1.5 Market by Application
1.5.1 Global Transdermal and Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Transdermal and Transmucosal Drug Delivery Industry Impact
1.6.1 How the Covid-19 is Affecting the Transdermal and Transmucosal Drug Delivery Industry
1.6.1.1 Transdermal and Transmucosal Drug Delivery Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Transdermal and Transmucosal Drug Delivery Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Transdermal and Transmucosal Drug Delivery Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Transdermal and Transmucosal Drug Delivery Market Perspective (2015-2026)
2.2 Transdermal and Transmucosal Drug Delivery Growth Trends by Regions
2.2.1 Transdermal and Transmucosal Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Transdermal and Transmucosal Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Transdermal and Transmucosal Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Transdermal and Transmucosal Drug Delivery Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Transdermal and Transmucosal Drug Delivery Players by Market Size
3.1.1 Global Top Transdermal and Transmucosal Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Transdermal and Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Transdermal and Transmucosal Drug Delivery Market Concentration Ratio
3.2.1 Global Transdermal and Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Transdermal and Transmucosal Drug Delivery Revenue in 2019
3.3 Transdermal and Transmucosal Drug Delivery Key Players Head office and Area Served
3.4 Key Players Transdermal and Transmucosal Drug Delivery Product Solution and Service
3.5 Date of Enter into Transdermal and Transmucosal Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Transdermal and Transmucosal Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Type (2021-2026)
5 TRANSDERMAL AND TRANSMUCOSAL DRUG DELIVERY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
5.2 Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
6.2 Transdermal and Transmucosal Drug Delivery Key Players in North America (2019-2020)
6.3 North America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
6.4 North America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
7.2 Transdermal and Transmucosal Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
8 CHINA
8.1 China Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
8.2 Transdermal and Transmucosal Drug Delivery Key Players in China (2019-2020)
8.3 China Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
8.4 China Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
9.2 Transdermal and Transmucosal Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
10.2 Transdermal and Transmucosal Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
11 INDIA
11.1 India Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
11.2 Transdermal and Transmucosal Drug Delivery Key Players in India (2019-2020)
11.3 India Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
11.4 India Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Transdermal and Transmucosal Drug Delivery Market Size (2015-2020)
12.2 Transdermal and Transmucosal Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 3M
13.1.1 3M Company Details
13.1.2 3M Business Overview and Its Total Revenue
13.1.3 3M Transdermal and Transmucosal Drug Delivery Introduction
13.1.4 3M Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020))
13.1.5 3M Recent Development
13.2 Antares Pharma
13.2.1 Antares Pharma Company Details
13.2.2 Antares Pharma Business Overview and Its Total Revenue
13.2.3 Antares Pharma Transdermal and Transmucosal Drug Delivery Introduction
13.2.4 Antares Pharma Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.2.5 Antares Pharma Recent Development
13.3 Aveva Drug Delivery Systems
13.3.1 Aveva Drug Delivery Systems Company Details
13.3.2 Aveva Drug Delivery Systems Business Overview and Its Total Revenue
13.3.3 Aveva Drug Delivery Systems Transdermal and Transmucosal Drug Delivery Introduction
13.3.4 Aveva Drug Delivery Systems Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.3.5 Aveva Drug Delivery Systems Recent Development
13.4 Corium International
13.4.1 Corium International Company Details
13.4.2 Corium International Business Overview and Its Total Revenue
13.4.3 Corium International Transdermal and Transmucosal Drug Delivery Introduction
13.4.4 Corium International Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.4.5 Corium International Recent Development
13.5 DURECT
13.5.1 DURECT Company Details
13.5.2 DURECT Business Overview and Its Total Revenue
13.5.3 DURECT Transdermal and Transmucosal Drug Delivery Introduction
13.5.4 DURECT Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.5.5 DURECT Recent Development
13.6 Pantec Biosolutions
13.6.1 Pantec Biosolutions Company Details
13.6.2 Pantec Biosolutions Business Overview and Its Total Revenue
13.6.3 Pantec Biosolutions Transdermal and Transmucosal Drug Delivery Introduction
13.6.4 Pantec Biosolutions Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.6.5 Pantec Biosolutions Recent Development
13.7 Tapemark
13.7.1 Tapemark Company Details
13.7.2 Tapemark Business Overview and Its Total Revenue
13.7.3 Tapemark Transdermal and Transmucosal Drug Delivery Introduction
13.7.4 Tapemark Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.7.5 Tapemark Recent Development
13.8 Tesa Labtec
13.8.1 Tesa Labtec Company Details
13.8.2 Tesa Labtec Business Overview and Its Total Revenue
13.8.3 Tesa Labtec Transdermal and Transmucosal Drug Delivery Introduction
13.8.4 Tesa Labtec Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
13.8.5 Tesa Labtec Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Transdermal and Transmucosal Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Transdermal and Transmucosal Drug Delivery Revenue
Table 3. Ranking of Global Top Transdermal and Transmucosal Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transdermal and Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transdermal Drug Delivery
Table 6. Key Players of Transmucosal Drug Delivery
Table 7. COVID-19 Impact Global Market: (Four Transdermal and Transmucosal Drug Delivery Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Transdermal and Transmucosal Drug Delivery Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Transdermal and Transmucosal Drug Delivery Players to Combat Covid-19 Impact
Table 12. Global Transdermal and Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Transdermal and Transmucosal Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Transdermal and Transmucosal Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions (2015-2020)
Table 16. Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Transdermal and Transmucosal Drug Delivery Market Growth Strategy
Table 22. Main Points Interviewed from Key Transdermal and Transmucosal Drug Delivery Players
Table 23. Global Transdermal and Transmucosal Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 24. Global Transdermal and Transmucosal Drug Delivery Market Share by Players (2015-2020)
Table 25. Global Top Transdermal and Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal and Transmucosal Drug Delivery as of 2019)
Table 26. Global Transdermal and Transmucosal Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Transdermal and Transmucosal Drug Delivery Product Solution and Service
Table 29. Date of Enter into Transdermal and Transmucosal Drug Delivery Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 32. Global Transdermal and Transmucosal Drug Delivery Market Size Share by Type (2015-2020)
Table 33. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Type (2021-2026)
Table 34. Global Transdermal and Transmucosal Drug Delivery Market Size Share by Application (2015-2020)
Table 35. Global Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 36. Global Transdermal and Transmucosal Drug Delivery Market Size Share by Application (2021-2026)
Table 37. North America Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 39. North America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 40. North America Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 41. North America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 42. North America Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 43. Europe Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 45. Europe Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 47. Europe Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 49. China Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 50. China Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 51. China Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 52. China Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 53. China Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 54. China Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 55. Japan Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 57. Japan Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 59. Japan Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 63. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 65. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 67. India Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 68. India Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 69. India Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 70. India Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 71. India Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 72. India Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 75. Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 77. Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 79. 3M Company Details
Table 80. 3M Business Overview
Table 81. 3M Product
Table 82. 3M Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 83. 3M Recent Development
Table 84. Antares Pharma Company Details
Table 85. Antares Pharma Business Overview
Table 86. Antares Pharma Product
Table 87. Antares Pharma Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 88. Antares Pharma Recent Development
Table 89. Aveva Drug Delivery Systems Company Details
Table 90. Aveva Drug Delivery Systems Business Overview
Table 91. Aveva Drug Delivery Systems Product
Table 92. Aveva Drug Delivery Systems Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 93. Aveva Drug Delivery Systems Recent Development
Table 94. Corium International Company Details
Table 95. Corium International Business Overview
Table 96. Corium International Product
Table 97. Corium International Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 98. Corium International Recent Development
Table 99. DURECT Company Details
Table 100. DURECT Business Overview
Table 101. DURECT Product
Table 102. DURECT Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 103. DURECT Recent Development
Table 104. Pantec Biosolutions Company Details
Table 105. Pantec Biosolutions Business Overview
Table 106. Pantec Biosolutions Product
Table 107. Pantec Biosolutions Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 108. Pantec Biosolutions Recent Development
Table 109. Tapemark Company Details
Table 110. Tapemark Business Overview
Table 111. Tapemark Product
Table 112. Tapemark Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 113. Tapemark Recent Development
Table 114. Tesa Labtec Business Overview
Table 115. Tesa Labtec Product
Table 116. Tesa Labtec Company Details
Table 117. Tesa Labtec Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 118. Tesa Labtec Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 1. Transdermal and Transmucosal Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Transdermal and Transmucosal Drug Delivery Revenue
Table 3. Ranking of Global Top Transdermal and Transmucosal Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Transdermal and Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Transdermal Drug Delivery
Table 6. Key Players of Transmucosal Drug Delivery
Table 7. COVID-19 Impact Global Market: (Four Transdermal and Transmucosal Drug Delivery Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Transdermal and Transmucosal Drug Delivery Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Transdermal and Transmucosal Drug Delivery Players to Combat Covid-19 Impact
Table 12. Global Transdermal and Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Transdermal and Transmucosal Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Transdermal and Transmucosal Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions (2015-2020)
Table 16. Global Transdermal and Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Transdermal and Transmucosal Drug Delivery Market Growth Strategy
Table 22. Main Points Interviewed from Key Transdermal and Transmucosal Drug Delivery Players
Table 23. Global Transdermal and Transmucosal Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 24. Global Transdermal and Transmucosal Drug Delivery Market Share by Players (2015-2020)
Table 25. Global Top Transdermal and Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal and Transmucosal Drug Delivery as of 2019)
Table 26. Global Transdermal and Transmucosal Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Transdermal and Transmucosal Drug Delivery Product Solution and Service
Table 29. Date of Enter into Transdermal and Transmucosal Drug Delivery Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 32. Global Transdermal and Transmucosal Drug Delivery Market Size Share by Type (2015-2020)
Table 33. Global Transdermal and Transmucosal Drug Delivery Revenue Market Share by Type (2021-2026)
Table 34. Global Transdermal and Transmucosal Drug Delivery Market Size Share by Application (2015-2020)
Table 35. Global Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 36. Global Transdermal and Transmucosal Drug Delivery Market Size Share by Application (2021-2026)
Table 37. North America Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 39. North America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 40. North America Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 41. North America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 42. North America Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 43. Europe Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 45. Europe Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 47. Europe Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 49. China Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 50. China Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 51. China Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 52. China Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 53. China Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 54. China Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 55. Japan Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 57. Japan Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 59. Japan Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 63. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 65. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 67. India Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 68. India Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 69. India Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 70. India Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 71. India Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 72. India Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Transdermal and Transmucosal Drug Delivery Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Transdermal and Transmucosal Drug Delivery Market Share (2019-2020)
Table 75. Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Transdermal and Transmucosal Drug Delivery Market Share by Type (2015-2020)
Table 77. Central & South America Transdermal and Transmucosal Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Transdermal and Transmucosal Drug Delivery Market Share by Application (2015-2020)
Table 79. 3M Company Details
Table 80. 3M Business Overview
Table 81. 3M Product
Table 82. 3M Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 83. 3M Recent Development
Table 84. Antares Pharma Company Details
Table 85. Antares Pharma Business Overview
Table 86. Antares Pharma Product
Table 87. Antares Pharma Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 88. Antares Pharma Recent Development
Table 89. Aveva Drug Delivery Systems Company Details
Table 90. Aveva Drug Delivery Systems Business Overview
Table 91. Aveva Drug Delivery Systems Product
Table 92. Aveva Drug Delivery Systems Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 93. Aveva Drug Delivery Systems Recent Development
Table 94. Corium International Company Details
Table 95. Corium International Business Overview
Table 96. Corium International Product
Table 97. Corium International Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 98. Corium International Recent Development
Table 99. DURECT Company Details
Table 100. DURECT Business Overview
Table 101. DURECT Product
Table 102. DURECT Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 103. DURECT Recent Development
Table 104. Pantec Biosolutions Company Details
Table 105. Pantec Biosolutions Business Overview
Table 106. Pantec Biosolutions Product
Table 107. Pantec Biosolutions Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 108. Pantec Biosolutions Recent Development
Table 109. Tapemark Company Details
Table 110. Tapemark Business Overview
Table 111. Tapemark Product
Table 112. Tapemark Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 113. Tapemark Recent Development
Table 114. Tesa Labtec Business Overview
Table 115. Tesa Labtec Product
Table 116. Tesa Labtec Company Details
Table 117. Tesa Labtec Revenue in Transdermal and Transmucosal Drug Delivery Business (2015-2020) (Million US$)
Table 118. Tesa Labtec Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Transdermal and Transmucosal Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Transdermal Drug Delivery Features
Figure 3. Transmucosal Drug Delivery Features
Figure 4. Global Transdermal and Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Transdermal and Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 11. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Transdermal and Transmucosal Drug Delivery Market Share by Players in 2019
Figure 14. Global Top Transdermal and Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal and Transmucosal Drug Delivery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Transdermal and Transmucosal Drug Delivery Revenue in 2019
Figure 16. North America Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. 3M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. 3M Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 25. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Antares Pharma Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 27. Aveva Drug Delivery Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Aveva Drug Delivery Systems Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 29. Corium International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Corium International Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 31. DURECT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. DURECT Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 33. Pantec Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pantec Biosolutions Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 35. Tapemark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Tapemark Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 37. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Tesa Labtec Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Figure 1. Global Transdermal and Transmucosal Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Transdermal Drug Delivery Features
Figure 3. Transmucosal Drug Delivery Features
Figure 4. Global Transdermal and Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Transdermal and Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transdermal and Transmucosal Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 11. Global Transdermal and Transmucosal Drug Delivery Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Transdermal and Transmucosal Drug Delivery Market Share by Players in 2019
Figure 14. Global Top Transdermal and Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal and Transmucosal Drug Delivery as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Transdermal and Transmucosal Drug Delivery Revenue in 2019
Figure 16. North America Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Transdermal and Transmucosal Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. 3M Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. 3M Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 25. Antares Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Antares Pharma Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 27. Aveva Drug Delivery Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Aveva Drug Delivery Systems Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 29. Corium International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Corium International Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 31. DURECT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. DURECT Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 33. Pantec Biosolutions Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pantec Biosolutions Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 35. Tapemark Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Tapemark Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 37. Tesa Labtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Tesa Labtec Revenue Growth Rate in Transdermal and Transmucosal Drug Delivery Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
